| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.09 | 0.004 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |